{
    "Trade/Device Name(s)": [
        "EliATM CENP Immunoassay",
        "EliATM U1RNP Immunoassay",
        "EliA\u2122 Sm Immunoassay",
        "EliA\u2122 Ro Immunoassay",
        "EliA\u2122 La Immunoassay",
        "EliA CENP",
        "EliA U1RNP",
        "EliA Sm",
        "EliA Ro",
        "EliA La"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K082759",
    "Predicate Device Reference 510(k) Number(s)": [
        "K944171",
        "K993589",
        "K000312",
        "K922830",
        "K944168"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LJM"
    ],
    "Summary Letter Date": "April 3, 2009",
    "Summary Letter Received Date": "April 6, 2009",
    "Submission Date": "September 18, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to CENP",
        "IgG antibodies to U1RNP",
        "IgG antibodies to Sm",
        "IgG antibodies to Ro",
        "IgG antibodies to La"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100",
        "ImmunoCAP 250"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence Immunoassay",
        "Enzyme immunoassay (ELISA)"
    ],
    "Methodologies": [
        "Antibody detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for EliA Immunoassays measuring IgG antibodies to CENP, U1RNP, Sm, Ro, and La for autoimmune disease diagnosis using ImmunoCAP analyzers",
    "Indications for Use Summary": "For in vitro semi-quantitative measurement of IgG antibodies to CENP, U1RNP, Sm, Ro, and La in serum and plasma as an aid in diagnosis of scleroderma (CREST syndrome), mixed connective tissue disease, systemic lupus erythematosus, and Sj\u00f6gren's syndrome, to be used in conjunction with other laboratory and clinical findings",
    "fda_folder": "Immunology"
}